Instituto Europeo di Oncologia

Site:	Instituto Europeo di Oncologia
Address:
City:	Milano
State:
Zip:
Country:	Italy

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722